According to The Fly, merrill Lynch analyst Sachin Jain maintained a Buy rating on AstraZeneca (AZN) today. The company’s shares opened today at $39.15.
Jain has an average return of 11.4% when recommending AstraZeneca.
According to TipRanks.com, Jain is ranked #2549 out of 5108 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AstraZeneca with a $50.40 average price target, implying a 28.7% upside from current levels. In a report released yesterday, SunTrust Robinson also initiated coverage with a Buy rating on the stock with a $48 price target.
.
See today’s analyst top recommended stocks >>
Based on AstraZeneca’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $432 million. In comparison, last year the company had a net profit of $690 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases.
